Statistical limitations of percent ideal body weight as measure for nutritional failure in patients with cystic fibrosis  T.O. Hirche, H. Hirche, S. Jungblut,

Slides:



Advertisements
Similar presentations
Sleep quality and depression–anxiety in mothers of children with two chronic respiratory diseases: Asthma and cystic fibrosis  Ozge Yılmaz, Ayhan Sogut,
Advertisements

Pattern of Growth in Children with Cerebral Palsy
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
The prevalence of “risky behaviour” in adults with cystic fibrosis
Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus  Magnus Hillman, Leif Eriksson, Lena Mared, Karin Helgesson,
Zhumin Zhang, Suzanne M. Shoff, HuiChuan J. Lai 
Cystic fibrosis mortality trends in France
Zachary M. Sellers, Lori McGlocklin, Andrea Brasch 
HbA1c as a screening tool for cystic fibrosis related diabetes
Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10years old  Millie Garg, Steven T. Leach, Tamara.
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
Assessment of nutritional status in children with cystic fibrosis: conventional anthropometry and bioelectrical impedance analysis. A cross-sectional.
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Sleep quality and depression–anxiety in mothers of children with two chronic respiratory diseases: Asthma and cystic fibrosis  Ozge Yılmaz, Ayhan Sogut,
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Early attained weight and length predict growth faltering better than velocity measures in infants with CF  Sonya L. Heltshe, Drucy S. Borowitz, Daniel.
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
John Widger, Sarath Ranganathan, Philip J. Robinson 
Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study  Matthew N. Hurley, Tricia M. McKeever,
Delayed publication of clinical trials in cystic fibrosis
An unusual cause of growth failure in cystic fibrosis: A salutary reminder of the interaction between glucocorticoids and cytochrome P450 inhibiting medication 
The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population  Brandie D. Wagner, Frank J. Accurso,
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Evaluation of salt supplementation in CF infants
The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation  Verena I. Seliger, David Rodman, Fredrick Van.
Nutritional status is associated with health-related quality of life in children with cystic fibrosis aged 9–19years  Suzanne M. Shoff, Audrey Tluczek,
Ghrelin and leptin levels in young adults with cystic fibrosis: Relationship with body fat  Charilaos Stylianou, Assimina Galli-Tsinopoulou, George Koliakos,
Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis
A.H. Gifford  Journal of Cystic Fibrosis 
Demographics of glucose metabolism in cystic fibrosis
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis  Sanja Stanojevic, Valerie Waters, Joseph L.
Physiologic endpoints for clinical studies for cystic fibrosis
Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: A reconsideration  Drucy Borowitz, Daniel Gelfond, Karen.
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Depression and anxiety in adolescents and adults with cystic fibrosis in the UK: A cross- sectional study  Alistair J.A. Duff, Janice Abbott, Carolyn Cowperthwaite,
Calculation of the capnographic index based on expiratory molar mass–volume-curves — A suitable tool to screen for cystic fibrosis lung disease  Susanne.
Cytokine gene polymorphisms and severity of CF lung disease
Chee Y. Ooi, Peter R. Durie  Journal of Cystic Fibrosis 
Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis  K.L. Moffitt, S.L. Martin, A.M. Jones, A.K. Webb,
D.Y.F. Mak, J. Sykes, A.L. Stephenson, L.C. Lands 
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
Ruth H. Keogh, Sanja Stanojevic  Journal of Cystic Fibrosis 
Determining presence of lung disease in young children with cystic fibrosis: Lung clearance index, oxygen saturation and cough frequency  E.M. Bakker,
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening  Steven Keiles, Ruth Koepke, Richard.
Michael W. Konstan, David J. Pasta, Jeffrey S. Wagener, Donald R
Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis  Hanne Vebert Olesen, Uffe Holmskov, Peter Oluf Schiøtz, Grith Lykke Sørensen 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
Gut dysbiosis in cystic fibrosis
CFTR modulators and pregnancy: Our work has only just begun
Sophie Yammine, Florian Singer, Per Gustafsson, Philipp Latzin 
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis
Michael W. Konstan, Jeffrey S. Wagener, Donald R. VanDevanter, David J
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis  D.J. Touw, A.J. Knox,
Absence of a gender gap in survival
Presentation transcript:

Statistical limitations of percent ideal body weight as measure for nutritional failure in patients with cystic fibrosis  T.O. Hirche, H. Hirche, S. Jungblut, M. Stern, T.O. Wagner, B. Wiedemann  Journal of Cystic Fibrosis  Volume 8, Issue 4, Pages 238-244 (July 2009) DOI: 10.1016/j.jcf.2009.03.004 Copyright © 2009 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 a, Scatter-plot of height and weight for 16 year old healthy girls (n=120) from the German National Nutrition Survey I. Height- and weight-for-age reference percentiles used were from a large set of healthy German children [20]. Bold line, line of identity for corresponding height- and weight-for-age percentiles, according to the ideal weight assumed by the %IBW method. b, Schematic drawing of the above scatter-plot in (a). The local distributions of weight at specific height-for-age percentiles are illustrated by Gaussian curves, the midpoints of which correspond to the best estimation of mean weight at that height in the subgroup described in (a). These midpoints can be connected by the line of regression (dashed line; log (weight)=b+a⁎height) for best estimation of ideal weight-for-age vs. height-for-age in the reference population. Journal of Cystic Fibrosis 2009 8, 238-244DOI: (10.1016/j.jcf.2009.03.004) Copyright © 2009 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 Scatter-plot of height and weight for 10 year old boys with CF (n=955) from the CFQA project. Height- and weight-for-age reference percentiles used were from a large set of healthy German children [20]. Bold line, line of identity for height- and weight-for-age percentiles; dashed line, regression line (log (weight)=b+a⁎height) of the corresponding reference population, respectively. Journal of Cystic Fibrosis 2009 8, 238-244DOI: (10.1016/j.jcf.2009.03.004) Copyright © 2009 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 Relation of height and weight percentiles of (a) healthy children (n=3849) from the German National Nutrition Survey I and (b) children with CF (n=4577) from the CFQA project. Subgroups defined by height percentile decades were aligned with their corresponding means of weight percentiles. Note the marked regression of weight percentile means to the centre of the reference population. Horizontal bars represent the total median percentiles of healthy and CF-children relative to the reference population. Journal of Cystic Fibrosis 2009 8, 238-244DOI: (10.1016/j.jcf.2009.03.004) Copyright © 2009 European Cystic Fibrosis Society Terms and Conditions